Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Su-Ling Loo

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
F1000Research|September 10, 2016
Recent advances in understanding and managing asthmaSu-Ling Loo, Peter A B Wark
American Journal of Physiology. Lung Cellular and Molecular Physiology|September 9, 2020
Human coronaviruses 229E and OC43 replicate and induce distinct antiviral responses in differentiated primary human bronchial epithelial cellsSu-Ling Loo, Peter A B Wark, Camille Esneau, et al.
Drug Delivery and Translational Research|July 8, 2026
A targeted antioxidant nanomedicine regulates mitochondrial ROS and antiviral immunity in rhinovirus-infected human bronchial epithelial cellsThomas J Adams, Michael Schuliga, Su Ling Loo, et al.
American Journal of Respiratory Cell and Molecular Biology|August 21, 2023
Upper Respiratory Tract OC43 Infection Model for Investigating Airway Immune-Modifying TherapiesJason L N Girkin, Nathan E Bryant, Su-Ling Loo, et al.
The European Respiratory Journal|December 11, 2020
TLR2-mediated innate immune priming boosts lung anti-viral immunityJason Girkin, Su-Ling Loo, Camille Esneau, et al.
The Journal of Allergy and Clinical Immunology|October 17, 2020
Inhaled corticosteroids downregulate the SARS-CoV-2 receptor ACE2 in COPD through suppression of type I interferonLydia J Finney, Nicholas Glanville, Hugo Farne, et al.
Communications Biology|May 4, 2022
IL-25 blockade augments antiviral immunity during respiratory virus infectionTeresa C Williams, Su-Ling Loo, Kristy S Nichol, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|September 13, 2019
Antiviral immunity is impaired in COPD patients with frequent exacerbationsAran Singanayagam, Su-Ling Loo, Maria Calderazzo, et al.
American Journal of Respiratory Cell and Molecular Biology|December 2, 2020
Rhinovirus-induced CCL17 and CCL22 in Asthma Exacerbations and Differential Regulation by STAT6Teresa C Williams, David J Jackson, Steven Maltby, et al.
Nature Communications|June 10, 2018
Corticosteroid suppression of antiviral immunity increases bacterial loads and mucus production in COPD exacerbationsAran Singanayagam, Nicholas Glanville, Jason L Girkin, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
F1000Research|September 10, 2016
Recent advances in understanding and managing asthmaSu-Ling Loo, Peter A B Wark
American Journal of Physiology. Lung Cellular and Molecular Physiology|September 9, 2020
Human coronaviruses 229E and OC43 replicate and induce distinct antiviral responses in differentiated primary human bronchial epithelial cellsSu-Ling Loo, Peter A B Wark, Camille Esneau, et al.
Drug Delivery and Translational Research|July 8, 2026
A targeted antioxidant nanomedicine regulates mitochondrial ROS and antiviral immunity in rhinovirus-infected human bronchial epithelial cellsThomas J Adams, Michael Schuliga, Su Ling Loo, et al.
American Journal of Respiratory Cell and Molecular Biology|August 21, 2023
Upper Respiratory Tract OC43 Infection Model for Investigating Airway Immune-Modifying TherapiesJason L N Girkin, Nathan E Bryant, Su-Ling Loo, et al.
The European Respiratory Journal|December 11, 2020
TLR2-mediated innate immune priming boosts lung anti-viral immunityJason Girkin, Su-Ling Loo, Camille Esneau, et al.
The Journal of Allergy and Clinical Immunology|October 17, 2020
Inhaled corticosteroids downregulate the SARS-CoV-2 receptor ACE2 in COPD through suppression of type I interferonLydia J Finney, Nicholas Glanville, Hugo Farne, et al.
Communications Biology|May 4, 2022
IL-25 blockade augments antiviral immunity during respiratory virus infectionTeresa C Williams, Su-Ling Loo, Kristy S Nichol, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|September 13, 2019
Antiviral immunity is impaired in COPD patients with frequent exacerbationsAran Singanayagam, Su-Ling Loo, Maria Calderazzo, et al.
American Journal of Respiratory Cell and Molecular Biology|December 2, 2020
Rhinovirus-induced CCL17 and CCL22 in Asthma Exacerbations and Differential Regulation by STAT6Teresa C Williams, David J Jackson, Steven Maltby, et al.
Nature Communications|June 10, 2018
Corticosteroid suppression of antiviral immunity increases bacterial loads and mucus production in COPD exacerbationsAran Singanayagam, Nicholas Glanville, Jason L Girkin, et al.
Pageof 1